In this study, we showed that the rate of FGFR2 gene amplification was higher in GC than in other types of cancer, consistent with previous studies [17, 22, 25] indicating an incidence of FGFR2 amplification in GC of approximately 1.3%. This evidence concerns the gene FGFR2 and cancer.